Log In
BCIQ
Print this Print this
 

formerly CBM588

  Manage Alerts
Collapse Summary General Information
Company Osel Inc.
DescriptionOral product containing the probiotic bacterium Clostridium butyricum
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase II
Standard IndicationClostridium
Indication DetailsTreat Clostridium difficile-associated disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today